20.51
1.33%
+0.27
Denali Therapeutics Inc (DNLI) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
100.00%
-
|
1.267 | 294.12 | 35.14 | 10.28 |
Operating Expenses
|
15.22%
132.57
|
115.06 | 123.64 | 155.96 | 115.63 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
15.22%
132.57
|
115.06 | 123.64 | 155.96 | 115.63 |
Operating Income/Loss |
16.50%
-132.57
|
-113.80 | 170.48 | -120.81 | -105.34 |
Nonoperating Income/Loss |
9.09%
13.13
|
14.44 | 12.90 | 11.03 | 6.66 |
Income/Loss From Continuing Operations Before Tax |
100.00%
-
|
1.267 | 294.12 | 35.14 | 10.28 |
Income Tax Expense/Benefit |
0.03
|
- | - | - | -0.006 |
Income/Loss From Continuing Operations After Tax |
20.25%
-119.47
|
-99.35 | 183.38 | -109.78 | -98.68 |
Net Income/Loss
|
20.25%
-119.47
|
-99.35 | 183.38 | -109.78 | -98.68 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.79%
0.2947
|
137.64 | 137.05 | 136.52 | 2.4758 |
Diluted Average Shares |
99.79%
0.2947
|
137.64 | 140.93 | 136.52 | 2.4758 |
Basic Earnings Per Share |
20.83%
-0.87
|
-0.72 | 1.34 | -0.80 | -0.75 |
Diluted Earnings Per Share |
20.83%
-0.87
|
-0.72 | 1.30 | -0.80 | -0.75 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):